BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Arcus shifts effort, bears down on would-be ‘anchor’ in RCC
Arcus Biosciences Inc. and partner Gilead Sciences Inc. are scrapping phase III work with anti-TIGIT antibody domvanalimab after an independent data monitoring committee...

More in BioWorld

BioWorld MedTech

FDA greenlights Medtronic Onyx subdural hematoma treatment
Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid...

More in BioWorld MedTech

BioWorld Science

Research unpicks molecular mechanism of vaccine-induced cardiac inflammation
The cardiomyositis that is a rare adverse effect of mRNA-based COVID vaccines is due to immune cell activity as a result of increased levels of the chemokines CXCL10 and...

More in BioWorld Science

BioWorld Asia

Immutep shares rocket on AU$528M deal with Dr. Reddy’s
Immutep Ltd.’s stock surged 31% on Tuesday morning following the news that it out-licensed rights to Dr. Reddy’s Laboratories Ltd. to develop and commercialize eftilagimod...

More in BioWorld Asia

BioWorld Insider podcast

The opioid crisis may not be front and center anymore, but it’s raging still. Elysium Therapeutics Inc. CEO Greg Sturmer talks about his firm’s candidate for a solution to the medical and societal problem.